 | • レポートコード：20QY06-00225 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、DTベース混合ワクチンのグローバル市場について種類別（合併症防止、異株・血清型病気防止）、用途別（子供、大人、高齢者、妊娠）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・DTベース混合ワクチン市場の概要 ・世界の主要地域別DTベース混合ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のDTベース混合ワクチン市場規模2015-2026：種類別（合併症防止、異株・血清型病気防止） ・世界のDTベース混合ワクチン市場規模2015-2026：用途別（子供、大人、高齢者、妊娠） ・DTベース混合ワクチンの北米市場規模2015-2020 ・DTベース混合ワクチンのヨーロッパ市場規模2015-2020 ・DTベース混合ワクチンの中国市場規模2015-2020 ・DTベース混合ワクチンの日本市場規模2015-2020 ・DTベース混合ワクチンの東南アジア市場規模2015-2020 ・DTベース混合ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （GSK、Changsheng、CCBIO、Aleph Biomedical、Sanofi、Lanzhou Institute Of Biological Product、Siobp、Hualan Bio、Tianyuan Bio-Pharma、Vaxtec、Hissen、Abbott、Novartis、Tasly&Jenner、Tiantan） ・DTベース混合ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・DTベース混合ワクチンの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global DT-Based Combined Vaccines Market
The global DT-Based Combined Vaccines market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global DT-Based Combined Vaccines Scope and Market Size
The global DT-Based Combined Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global DT-Based Combined Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the DT-Based Combined Vaccines market is segmented into
Protect Against Two or More Diseases
Protect Against One Disease Caused by Different Strains or Serotypes
Segment by Application, the DT-Based Combined Vaccines market is segmented into
Children
Adults
Elderly
Pregnancy
The DT-Based Combined Vaccines market is analysed and market size information is provided by regions (countries). Segment by Application, the DT-Based Combined Vaccines market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and DT-Based Combined Vaccines Market Share Analysis
DT-Based Combined Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in DT-Based Combined Vaccines business, the date to enter into the DT-Based Combined Vaccines market, DT-Based Combined Vaccines product introduction, recent developments, etc.
The major vendors covered:
GSK
Changsheng
CCBIO
Aleph Biomedical
Sanofi
Lanzhou Institute Of Biological Product
Siobp
Hualan Bio
Tianyuan Bio-Pharma
Vaxtec
Hissen
Abbott
Novartis
Tasly&Jenner
Tiantan
Table of Contents
1 DT-Based Combined Vaccines Market Overview
1.1 DT-Based Combined Vaccines Product Scope
1.2 DT-Based Combined Vaccines Segment by Type
1.2.1 Global DT-Based Combined Vaccines Sales by Type (2020-2026)
1.2.2 Protect Against Two or More Diseases
1.2.3 Protect Against One Disease Caused by Different Strains or Serotypes
1.3 DT-Based Combined Vaccines Segment by Application
1.3.1 Global DT-Based Combined Vaccines Sales Comparison by Application (2020-2026)
1.3.2 Children
1.3.3 Adults
1.3.4 Elderly
1.3.5 Pregnancy
1.4 DT-Based Combined Vaccines Market Estimates and Forecasts (2015-2026)
1.4.1 Global DT-Based Combined Vaccines Sales Growth Rate (2015-2026)
1.4.2 Global DT-Based Combined Vaccines Revenue and Growth Rate (2015-2026)
1.4.3 Global DT-Based Combined Vaccines Price Trends (2015-2026)
2 DT-Based Combined Vaccines Estimate and Forecast by Region
2.1 Global DT-Based Combined Vaccines Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global DT-Based Combined Vaccines Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global DT-Based Combined Vaccines Sales Market Share by Region (2015-2020)
2.2.2 Global DT-Based Combined Vaccines Revenue Market Share by Region (2015-2020)
2.3 Global DT-Based Combined Vaccines Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global DT-Based Combined Vaccines Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global DT-Based Combined Vaccines Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States DT-Based Combined Vaccines Estimates and Projections (2015-2026)
2.4.2 Europe DT-Based Combined Vaccines Estimates and Projections (2015-2026)
2.4.3 China DT-Based Combined Vaccines Estimates and Projections (2015-2026)
2.4.4 Japan DT-Based Combined Vaccines Estimates and Projections (2015-2026)
2.4.5 Southeast Asia DT-Based Combined Vaccines Estimates and Projections (2015-2026)
2.4.6 India DT-Based Combined Vaccines Estimates and Projections (2015-2026)
3 Global DT-Based Combined Vaccines Competition Landscape by Players
3.1 Global Top DT-Based Combined Vaccines Players by Sales (2015-2020)
3.2 Global Top DT-Based Combined Vaccines Players by Revenue (2015-2020)
3.3 Global DT-Based Combined Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DT-Based Combined Vaccines as of 2019)
3.4 Global DT-Based Combined Vaccines Average Price by Company (2015-2020)
3.5 Manufacturers DT-Based Combined Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key DT-Based Combined Vaccines Players (Opinion Leaders)
4 Global DT-Based Combined Vaccines Market Size by Type
4.1 Global DT-Based Combined Vaccines Historic Market Review by Type (2015-2020)
4.1.1 Global DT-Based Combined Vaccines Sales Market Share by Type (2015-2020)
4.1.2 Global DT-Based Combined Vaccines Revenue Market Share by Type (2015-2020)
4.1.3 Global DT-Based Combined Vaccines Price by Type (2014-2020)
4.2 Global DT-Based Combined Vaccines Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global DT-Based Combined Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global DT-Based Combined Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Global DT-Based Combined Vaccines Price Forecast by Type (2021-2026)
5 Global DT-Based Combined Vaccines Market Size by Application
5.1 Global DT-Based Combined Vaccines Historic Market Review by Application (2015-2020)
5.1.1 Global DT-Based Combined Vaccines Sales Market Share by Application (2015-2020)
5.1.2 Global DT-Based Combined Vaccines Revenue Market Share by Application (2015-2020)
5.1.3 Global DT-Based Combined Vaccines Price by Application (2015-2020)
5.2 Global DT-Based Combined Vaccines Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global DT-Based Combined Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global DT-Based Combined Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global DT-Based Combined Vaccines Price Forecast by Application (2021-2026)
3 North America DT-Based Combined Vaccines Market Facts & Figures
3.2 North America DT-Based Combined Vaccines Sales Market Share by Company (2015-2020)
3.3 North America DT-Based Combined Vaccines Sales Market Share by Type (2015-2020)
3.4 North America DT-Based Combined Vaccines Sales Market Share by Application (2015-2020)
4 Europe DT-Based Combined Vaccines Market Facts & Figures
4.2 Europe DT-Based Combined Vaccines Sales Market Share by Company (2015-2020)
4.3 Europe DT-Based Combined Vaccines Sales Market Share by Type (2015-2020)
4.4 Europe DT-Based Combined Vaccines Sales Market Share by Application (2015-2020)
5 China DT-Based Combined Vaccines Market Facts & Figures
5.2 China DT-Based Combined Vaccines Sales Market Share by Company (2015-2020)
5.3 China DT-Based Combined Vaccines Sales Market Share by Type (2015-2020)
5.4 China DT-Based Combined Vaccines Sales Market Share by Application (2015-2020)
6 Japan DT-Based Combined Vaccines Market Facts & Figures
6.2 Japan DT-Based Combined Vaccines Sales Market Share by Company (2015-2020)
6.3 Japan DT-Based Combined Vaccines Sales Market Share by Type (2015-2020)
6.4 Japan DT-Based Combined Vaccines Sales Market Share by Application (2015-2020)
7 Southeast Asia DT-Based Combined Vaccines Market Facts & Figures
7.2 Southeast Asia DT-Based Combined Vaccines Sales Market Share by Company (2015-2020)
7.3 Southeast Asia DT-Based Combined Vaccines Sales Market Share by Type (2015-2020)
7.4 Southeast Asia DT-Based Combined Vaccines Sales Market Share by Application (2015-2020)
8 India DT-Based Combined Vaccines Market Facts & Figures
8.2 India DT-Based Combined Vaccines Sales Market Share by Company (2015-2020)
8.3 India DT-Based Combined Vaccines Sales Market Share by Type (2015-2020)
8.4 India DT-Based Combined Vaccines Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in DT-Based Combined Vaccines Business
12.1 GSK
12.1.1 GSK DT-Based Combined Vaccines Corporation Information
12.1.2 GSK DT-Based Combined Vaccines Business Overview and Total Revenue
12.1.3 GSK DT-Based Combined Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GSK DT-Based Combined Vaccines Products Offered
12.1.5 GSK Recent Development
12.2 Changsheng
12.2.1 Changsheng DT-Based Combined Vaccines Corporation Information
12.2.2 Changsheng DT-Based Combined Vaccines Business Overview and Total Revenue
12.2.3 Changsheng DT-Based Combined Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Changsheng DT-Based Combined Vaccines Products Offered
12.2.5 Changsheng Recent Development
12.3 CCBIO
12.3.1 CCBIO DT-Based Combined Vaccines Corporation Information
12.3.2 CCBIO DT-Based Combined Vaccines Business Overview and Total Revenue
12.3.3 CCBIO DT-Based Combined Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.3.4 CCBIO DT-Based Combined Vaccines Products Offered
12.3.5 CCBIO Recent Development
12.4 Aleph Biomedical
12.4.1 Aleph Biomedical DT-Based Combined Vaccines Corporation Information
12.4.2 Aleph Biomedical DT-Based Combined Vaccines Business Overview and Total Revenue
12.4.3 Aleph Biomedical DT-Based Combined Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Aleph Biomedical DT-Based Combined Vaccines Products Offered
12.4.5 Aleph Biomedical Recent Development
12.5 Sanofi
12.5.1 Sanofi DT-Based Combined Vaccines Corporation Information
12.5.2 Sanofi DT-Based Combined Vaccines Business Overview and Total Revenue
12.5.3 Sanofi DT-Based Combined Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sanofi DT-Based Combined Vaccines Products Offered
12.5.5 Sanofi Recent Development
12.6 Lanzhou Institute Of Biological Product
12.6.1 Lanzhou Institute Of Biological Product DT-Based Combined Vaccines Corporation Information
12.6.2 Lanzhou Institute Of Biological Product DT-Based Combined Vaccines Business Overview and Total Revenue
12.6.3 Lanzhou Institute Of Biological Product DT-Based Combined Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Lanzhou Institute Of Biological Product DT-Based Combined Vaccines Products Offered
12.6.5 Lanzhou Institute Of Biological Product Recent Development
12.7 Siobp
12.7.1 Siobp DT-Based Combined Vaccines Corporation Information
12.7.2 Siobp DT-Based Combined Vaccines Business Overview and Total Revenue
12.7.3 Siobp DT-Based Combined Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Siobp DT-Based Combined Vaccines Products Offered
12.7.5 Siobp Recent Development
12.8 Hualan Bio
12.8.1 Hualan Bio DT-Based Combined Vaccines Corporation Information
12.8.2 Hualan Bio DT-Based Combined Vaccines Business Overview and Total Revenue
12.8.3 Hualan Bio DT-Based Combined Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Hualan Bio DT-Based Combined Vaccines Products Offered
12.8.5 Hualan Bio Recent Development
12.9 Tianyuan Bio-Pharma
12.9.1 Tianyuan Bio-Pharma DT-Based Combined Vaccines Corporation Information
12.9.2 Tianyuan Bio-Pharma DT-Based Combined Vaccines Business Overview and Total Revenue
12.9.3 Tianyuan Bio-Pharma DT-Based Combined Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Tianyuan Bio-Pharma DT-Based Combined Vaccines Products Offered
12.9.5 Tianyuan Bio-Pharma Recent Development
12.10 Vaxtec
12.10.1 Vaxtec DT-Based Combined Vaccines Corporation Information
12.10.2 Vaxtec DT-Based Combined Vaccines Business Overview and Total Revenue
12.10.3 Vaxtec DT-Based Combined Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Vaxtec DT-Based Combined Vaccines Products Offered
12.10.5 Vaxtec Recent Development
12.11 Hissen
12.11.1 Hissen DT-Based Combined Vaccines Corporation Information
12.11.2 Hissen DT-Based Combined Vaccines Business Overview and Total Revenue
12.11.3 Hissen DT-Based Combined Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Hissen DT-Based Combined Vaccines Products Offered
12.11.5 Hissen Recent Development
12.12 Abbott
12.12.1 Abbott DT-Based Combined Vaccines Corporation Information
12.12.2 Abbott DT-Based Combined Vaccines Business Overview and Total Revenue
12.12.3 Abbott DT-Based Combined Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Abbott DT-Based Combined Vaccines Products Offered
12.12.5 Abbott Recent Development
12.13 Novartis
12.13.1 Novartis DT-Based Combined Vaccines Corporation Information
12.13.2 Novartis DT-Based Combined Vaccines Business Overview and Total Revenue
12.13.3 Novartis DT-Based Combined Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Novartis DT-Based Combined Vaccines Products Offered
12.13.5 Novartis Recent Development
12.14 Tasly&Jenner
12.14.1 Tasly&Jenner DT-Based Combined Vaccines Corporation Information
12.14.2 Tasly&Jenner DT-Based Combined Vaccines Business Overview and Total Revenue
12.14.3 Tasly&Jenner DT-Based Combined Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Tasly&Jenner DT-Based Combined Vaccines Products Offered
12.14.5 Tasly&Jenner Recent Development
12.15 Tiantan
12.15.1 Tiantan DT-Based Combined Vaccines Corporation Information
12.15.2 Tiantan DT-Based Combined Vaccines Business Overview and Total Revenue
12.15.3 Tiantan DT-Based Combined Vaccines Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Tiantan DT-Based Combined Vaccines Products Offered
12.15.5 Tiantan Recent Development
13 DT-Based Combined Vaccines Manufacturing Cost Analysis
13.1 DT-Based Combined Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of DT-Based Combined Vaccines
13.4 DT-Based Combined Vaccines Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 DT-Based Combined Vaccines Distributors List
14.3 DT-Based Combined Vaccines Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global DT-Based Combined Vaccines Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global DT-Based Combined Vaccines Sales (K Doses) Comparison by Application (2020-2026)
Table 3. Global Market DT-Based Combined Vaccines Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global DT-Based Combined Vaccines Sales (K Doses) by Region (2015-2020)
Table 5. Global DT-Based Combined Vaccines Sales Market Share by Region (2015-2020)
Table 6. Global DT-Based Combined Vaccines Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global DT-Based Combined Vaccines Revenue Share by Region (2015-2020)
Table 8. Global DT-Based Combined Vaccines Sales (K Doses) Forecast by Region (2021-2026)
Table 9. Global DT-Based Combined Vaccines Sales Market Share Forecast by Region (2021-2026)
Table 10. Global DT-Based Combined Vaccines Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global DT-Based Combined Vaccines Revenue Share Forecast by Region (2021-2026)
Table 12. Global DT-Based Combined Vaccines (K Doses) of Key Companies (2015-2020)
Table 13. Global DT-Based Combined Vaccines Sales Share by Company (2015-2020)
Table 14. Global DT-Based Combined Vaccines Revenue (US$ Million) by Company (2015-2020)
Table 15. Global DT-Based Combined Vaccines Revenue Share by Company (2015-2020)
Table 16. Global DT-Based Combined Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DT-Based Combined Vaccines as of 2019)
Table 17. Global DT-Based Combined Vaccines Average Price (USD/Dose) of Key Company (2015-2020)
Table 18. Manufacturers DT-Based Combined Vaccines Manufacturing Sites and Area Served
Table 19. Manufacturers DT-Based Combined Vaccines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key DT-Based Combined Vaccines Players
Table 22. Global DT-Based Combined Vaccines Sales (K Doses) by Type (2015-2020)
Table 23. Global DT-Based Combined Vaccines Sales Share by Type (2015-2020)
Table 24. Global DT-Based Combined Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global DT-Based Combined Vaccines Price (K Doses) by Type (2015-2020)
Table 26. Global DT-Based Combined Vaccines Sales Share by Type (2021-2026)
Table 27. Global DT-Based Combined Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global DT-Based Combined Vaccines Revenue Share by Type (2021-2026)
Table 29. Global DT-Based Combined Vaccines Price (K Doses) by Type (2021-2026)
Table 30. Global DT-Based Combined Vaccines Sales (K Doses) by Application (2015-2020)
Table 31. Global DT-Based Combined Vaccines Sales Share by Application (2015-2020)
Table 32. Global DT-Based Combined Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global DT-Based Combined Vaccines Price (K Doses) by Application (2015-2020)
Table 34. Global DT-Based Combined Vaccines Sales (K Doses) by Application (2021-2026)
Table 35. Global DT-Based Combined Vaccines Sales Share by Application (2021-2026)
Table 36. Global DT-Based Combined Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global DT-Based Combined Vaccines Revenue Share by Application (2021-2026)
Table 38. Global DT-Based Combined Vaccines Price (K Doses) by Application (2021-2026)
Table 39. United States DT-Based Combined Vaccines Sales (K Doses) by Company (2015-2020)
Table 40. United States DT-Based Combined Vaccines Sales Market Share by Company (2015-2020)
Table 41. United States DT-Based Combined Vaccines Sales (K Doses) by Type (2015-2020)
Table 42. United States DT-Based Combined Vaccines Sales Market Share by Type (2015-2020)
Table 43. United States DT-Based Combined Vaccines Sales (K Doses) by Application (2015-2020)
Table 44. United States DT-Based Combined Vaccines Sales Market Share by Application (2015-2020)
Table 45. Europe DT-Based Combined Vaccines Sales (K Doses) by Company (2015-2020)
Table 46. Europe DT-Based Combined Vaccines Sales Market Share by Company (2015-2020)
Table 47. Europe DT-Based Combined Vaccines Sales (K Doses) by Type (2015-2020)
Table 48. Europe DT-Based Combined Vaccines Sales Market Share by Type (2015-2020)
Table 49. Europe DT-Based Combined Vaccines Sales (K Doses) by Application (2015-2020)
Table 50. Europe DT-Based Combined Vaccines Sales Market Share by Type (2015-2020)
Table 51. China DT-Based Combined Vaccines Sales (K Doses) by Company (2015-2020)
Table 52. China DT-Based Combined Vaccines Sales Market Share by Company (2015-2020)
Table 53. China DT-Based Combined Vaccines Sales (K Doses) by Type (2015-2020)
Table 54. China DT-Based Combined Vaccines Sales Market Share by Type (2015-2020)
Table 55. China DT-Based Combined Vaccines Sales (K Doses) by Application (2015-2020)
Table 56. China DT-Based Combined Vaccines Sales Market Share by Application (2015-2020)
Table 57. Japan DT-Based Combined Vaccines Sales (K Doses) by Company (2015-2020)
Table 58. Japan DT-Based Combined Vaccines Sales Market Share by Company (2015-2020)
Table 59. Japan DT-Based Combined Vaccines Sales (K Doses) by Type (2015-2020)
Table 60. Japan DT-Based Combined Vaccines Sales Market Share by Type (2015-2020)
Table 61. Japan DT-Based Combined Vaccines Sales (K Doses) by Application (2015-2020)
Table 62. Japan DT-Based Combined Vaccines Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia DT-Based Combined Vaccines Sales (K Doses) by Company (2015-2020)
Table 64. Southeast Asia DT-Based Combined Vaccines Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia DT-Based Combined Vaccines Sales (K Doses) by Type (2015-2020)
Table 66. Southeast Asia DT-Based Combined Vaccines Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia DT-Based Combined Vaccines Sales (K Doses) by Type (2015-2020)
Table 68. Southeast Asia DT-Based Combined Vaccines Sales Market Share by Application (2015-2020)
Table 69. India DT-Based Combined Vaccines Sales (K Doses) by Company (2015-2020)
Table 70. India DT-Based Combined Vaccines Sales Market Share by Company (2015-2020)
Table 71. India DT-Based Combined Vaccines Sales (K Doses) by Type (2015-2020)
Table 72. India DT-Based Combined Vaccines Sales Market Share by Type (2015-2020)
Table 73. India DT-Based Combined Vaccines Sales (K Doses) by Application (2015-2020)
Table 74. India DT-Based Combined Vaccines Sales Market Share by Application (2015-2020)
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK DT-Based Combined Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. GSK DT-Based Combined Vaccines Product
Table 79. GSK Recent Development
Table 80. Changsheng Corporation Information
Table 81. Changsheng Description and Business Overview
Table 82. Changsheng DT-Based Combined Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Changsheng DT-Based Combined Vaccines Product
Table 84. Changsheng Recent Development
Table 85. CCBIO Corporation Information
Table 86. CCBIO Description and Business Overview
Table 87. CCBIO DT-Based Combined Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. CCBIO DT-Based Combined Vaccines Product
Table 89. CCBIO Recent Development
Table 90. Aleph Biomedical Corporation Information
Table 91. Aleph Biomedical Description and Business Overview
Table 92. Aleph Biomedical DT-Based Combined Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Aleph Biomedical DT-Based Combined Vaccines Product
Table 94. Aleph Biomedical Recent Development
Table 95. Sanofi Corporation Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi DT-Based Combined Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Sanofi DT-Based Combined Vaccines Product
Table 99. Sanofi Recent Development
Table 100. Lanzhou Institute Of Biological Product Corporation Information
Table 101. Lanzhou Institute Of Biological Product Description and Business Overview
Table 102. Lanzhou Institute Of Biological Product DT-Based Combined Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Lanzhou Institute Of Biological Product DT-Based Combined Vaccines Product
Table 104. Lanzhou Institute Of Biological Product Recent Development
Table 105. Siobp Corporation Information
Table 106. Siobp Description and Business Overview
Table 107. Siobp DT-Based Combined Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Siobp DT-Based Combined Vaccines Product
Table 109. Siobp Recent Development
Table 110. Hualan Bio Corporation Information
Table 111. Hualan Bio DT-Based Combined Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 112. Hualan Bio Description and Business Overview
Table 113. Hualan Bio DT-Based Combined Vaccines Product
Table 114. Hualan Bio Recent Development
Table 115. Tianyuan Bio-Pharma Corporation Information
Table 116. Tianyuan Bio-Pharma DT-Based Combined Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 117. Tianyuan Bio-Pharma Description and Business Overview
Table 118. Tianyuan Bio-Pharma DT-Based Combined Vaccines Product
Table 119. Tianyuan Bio-Pharma Recent Development
Table 120. Vaxtec Corporation Information
Table 121. Vaxtec Description and Business Overview
Table 122. Vaxtec DT-Based Combined Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 123. Vaxtec DT-Based Combined Vaccines Product
Table 124. Vaxtec Recent Development
Table 125. Hissen Corporation Information
Table 126. Hissen Description and Business Overview
Table 127. Hissen DT-Based Combined Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Hissen DT-Based Combined Vaccines Product
Table 129. Hissen Recent Development
Table 130. Abbott Corporation Information
Table 131. Abbott Description and Business Overview
Table 132. Abbott DT-Based Combined Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 133. Abbott DT-Based Combined Vaccines Product
Table 134. Abbott Recent Development
Table 135. Novartis Corporation Information
Table 136. Novartis Description and Business Overview
Table 137. Novartis DT-Based Combined Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 138. Novartis DT-Based Combined Vaccines Product
Table 139. Novartis Recent Development
Table 140. Tasly&Jenner Corporation Information
Table 141. Tasly&Jenner Description and Business Overview
Table 142. Tasly&Jenner DT-Based Combined Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 143. Tasly&Jenner DT-Based Combined Vaccines Product
Table 144. Tasly&Jenner Recent Development
Table 145. Tiantan Corporation Information
Table 146. Tiantan Description and Business Overview
Table 147. Tiantan DT-Based Combined Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 148. Tiantan DT-Based Combined Vaccines Product
Table 149. Tiantan Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. DT-Based Combined Vaccines Distributors List
Table 153. DT-Based Combined Vaccines Customers List
Table 154. Market Key Trends
Table 155. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 156. Key Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. DT-Based Combined Vaccines Product Picture
Figure 2. Global DT-Based Combined Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global DT-Based Combined Vaccines Market Share by Application in 2020 & 2026
Figure 6. Children Examples
Figure 7. Adults Examples
Figure 8. Elderly Examples
Figure 9. Pregnancy Examples
Figure 10. Global DT-Based Combined Vaccines Sales (K Doses) Growth Rate (2015-2026)
Figure 11. Global DT-Based Combined Vaccines Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global DT-Based Combined Vaccines Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 13. Global DT-Based Combined Vaccines Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global DT-Based Combined Vaccines Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States DT-Based Combined Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States DT-Based Combined Vaccines Sales (K Doses) Growth Rate (2015-2026)
Figure 17. Europe DT-Based Combined Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe DT-Based Combined Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China DT-Based Combined Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China DT-Based Combined Vaccines Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan DT-Based Combined Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan DT-Based Combined Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia DT-Based Combined Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia DT-Based Combined Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India DT-Based Combined Vaccines Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India DT-Based Combined Vaccines Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest DT-Based Combined Vaccines Players Market Share by Revenue in DT-Based Combined Vaccines 2015 & 2019
Figure 28. DT-Based Combined Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global DT-Based Combined Vaccines Revenue Share by Type (2015-2020)
Figure 30. Global DT-Based Combined Vaccines Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global DT-Based Combined Vaccines Revenue Share by Application (2015-2020)
Figure 32. Global DT-Based Combined Vaccines Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States DT-Based Combined Vaccines Sales Market Share by Type in 2019
Figure 34. United States DT-Based Combined Vaccines Sales Market Share by Type in 2019
Figure 35. Europe DT-Based Combined Vaccines Sales Market Share by Company in 2019
Figure 36. Europe DT-Based Combined Vaccines Sales Market Share by Type in 2019
Figure 37. Europe DT-Based Combined Vaccines Sales Market Share by Application in 2019
Figure 38. China DT-Based Combined Vaccines Sales Market Share by Company in 2019
Figure 39. China DT-Based Combined Vaccines Sales Market Share by Type in 2019
Figure 40. China DT-Based Combined Vaccines Sales Market Share by Application in 2019
Figure 41. Japan DT-Based Combined Vaccines Sales Market Share by Company in 2019
Figure 42. Japan DT-Based Combined Vaccines Sales Market Share by Type in 2019
Figure 43. Japan DT-Based Combined Vaccines Sales Market Share by Application in 2019
Figure 44. Southeast Asia DT-Based Combined Vaccines Sales Market Share by Company in 2019
Figure 45. Southeast Asia DT-Based Combined Vaccines Sales Market Share by Type in 2019
Figure 46. Southeast Asia DT-Based Combined Vaccines Sales Market Share by Application in 2019
Figure 47. India DT-Based Combined Vaccines Sales Market Share by Company in 2019
Figure 48. India DT-Based Combined Vaccines Sales Market Share by Type in 2019
Figure 49. India DT-Based Combined Vaccines Sales Market Share by Application in 2019
Figure 50. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Changsheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. CCBIO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Aleph Biomedical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Lanzhou Institute Of Biological Product Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Siobp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Hualan Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Tianyuan Bio-Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Vaxtec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Hissen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Tasly&Jenner Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Tiantan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Key Raw Materials Price Trend
Figure 66. Manufacturing Cost Structure of DT-Based Combined Vaccines
Figure 67. Manufacturing Process Analysis of DT-Based Combined Vaccines
Figure 68. DT-Based Combined Vaccines Industrial Chain Analysis
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Figure 71. Porter's Five Forces Analysis
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
H7N9ワクチンの世界市場レポート2020 Market Analysis and Insights: Global H7N9 Vaccines Market The global H7N9 Vaccines market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global H7N9 Vaccines Scope and Market Size The global H7N9 Vaccines market is se…- HPV治療ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global HPV Therapeutic Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The HPV Therapeutic Vacc…
- 熱電併給（CHP）設置の世界市場レポート2020 Combined heat and power systems, also known as cogeneration, generate electricity and useful thermal energy in a single, integrated system. While the conventional method of producing usable heat and power separately has a typical combined efficiency of 45 percent, CHP systems can operate at levels a…
- 複合充電システムの世界市場レポート2020 A recently published report by QY Research titled Global Combined Charging System Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides ac…
- 単純ヘルペスウイルス（HSV）ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Herpes Simplex Virus (HSV) Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically …